title: Bacterial infection alters the kinetics and function of iNKT cell responses.
abstract: CD1d-restricted Valpha14 invariant NKT cells (iNKT) are innate-like, immunoregulatory lymphocytes that play critical roles in autoimmunity, tumor surveillance, and infectious disease. Although iNKT cells are activated during microbial infection, the impacts of infection on the function of iNKT cells have not been fully characterized. Using a Listeria monocytogenes (LM) infection model, we found that iNKT cells failed to expand after infection, resulting in prolonged loss in the spleen, in contrast to the typical expansion and contraction of conventional T cells. iNKT cells from LM-infected mice responded more rapidly to secondary LM infection; however, they became functionally hyporesponsive to antigenic challenge for at least 1 month. This infection-induced hyporesponsiveness was also induced by Mycobacteria infection and was more profound in LM-infected, thymectomized mice, suggesting that infection-primed iNKT cells might have altered functionality. Interestingly, activation with alpha-galactosylceramide-loaded dendritic cells was able to overcome infection-induced hyporesponsiveness of iNKT cells, suggesting a role for extrinsic factors in this functional deficit. Taken together, these findings suggest that infection affects iNKT cell responses quantitatively and qualitatively. As humans are under constant microbial insult, predictions of iNKT cell function based on naïve animal models may not accurately reflect iNKT cell behavior in a clinical setting.
authors.affiliation: Department of Pathology, University of Chicago, Chicago, IL, USA.
authors.forename: Hak-Jong
authors.initials: HJ
authors.lastname: Choi
authors.forename: Honglin
authors.initials: H
authors.lastname: Xu
authors.forename: Yanbiao
authors.initials: Y
authors.lastname: Geng
authors.forename: Angela
authors.initials: A
authors.lastname: Colmone
authors.forename: Hoonsik
authors.initials: H
authors.lastname: Cho
authors.forename: Chyung-Ru
authors.initials: CR
authors.lastname: Wang
mesh_terms: D000818:Animals; D017951:Antigen Presentation; D003713:Dendritic Cells / Q000276:immunology; D004195:Disease Models, Animal; D005434:Flow Cytometry; D016898:Interferon-alpha / Q000502:physiology; D008089:Listeria monocytogenes / Q000472:pathogenicity*; D008088:Listeriosis / Q000276:immunology* / Q000473:pathology; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009163:Mycobacterium bovis / Q000254:growth & development / Q000276:immunology / Q000472:pathogenicity; D009169:Mycobacterium tuberculosis / Q000276:immunology; D055611:Natural Killer T-Cells / Q000502:physiology*; D010641:Phenotype; D013154:Spleen / Q000276:immunology / Q000382:microbiology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
chemical_list: D016898:Interferon-alpha
references.citation: J Immunol. 2003 Aug 15;171(4):1775-9
references.pmid: 12902477
references.citation: Annu Rev Immunol. 2004;22:817-90
references.pmid: 15032598
references.citation: J Clin Invest. 2008 Jun;118(6):2301-15
references.pmid: 18451996
references.citation: Nat Immunol. 2006 Sep;7(9):978-86
references.pmid: 16921381
references.citation: Trends Immunol. 2007 Nov;28(11):491-6
references.pmid: 17964217
references.citation: Blood. 2004 Jan 15;103(2):383-9
references.pmid: 14512316
references.citation: Infect Immun. 2006 Oct;74(10):5903-13
references.pmid: 16988270
references.citation: J Immunol. 1997 Jul 1;159(1):7-10
references.pmid: 9200431
references.citation: Eur J Immunol. 2005 Mar;35(3):879-89
references.pmid: 15724241
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10913-8
references.pmid: 12960397
references.citation: Curr Opin Microbiol. 2004 Feb;7(1):45-50
references.pmid: 15036139
references.citation: Nat Med. 2002 Jun;8(6):588-93
references.pmid: 12042809
references.citation: Eur J Immunol. 2005 Jul;35(7):2100-9
references.pmid: 15940666
references.citation: J Exp Med. 2000 Sep 4;192(5):741-54
references.pmid: 10974039
references.citation: J Immunol. 2006 Dec 1;177(11):7841-8
references.pmid: 17114455
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13861-6
references.pmid: 12359878
references.citation: N Engl J Med. 2006 Mar 16;354(11):1117-29
references.pmid: 16540612
references.citation: Clin Immunol. 2008 Apr;127(1):1-6
references.pmid: 18304877
references.citation: J Exp Med. 2005 May 2;201(9):1503-17
references.pmid: 15867097
references.citation: J Immunol. 2002 Dec 1;169(11):6522-9
references.pmid: 12444163
references.citation: Clin Cancer Res. 2005 Mar 1;11(5):1910-7
references.pmid: 15756017
references.citation: J Exp Med. 2005 Nov 7;202(9):1279-88
references.pmid: 16275765
references.citation: Nat Immunol. 2000 Dec;1(6):459-60
references.pmid: 11101862
references.citation: Infect Immun. 2002 Nov;70(11):6302-9
references.pmid: 12379709
references.citation: J Immunol. 2005 Jul 15;175(2):1137-44
references.pmid: 16002715
references.citation: Clin Cancer Res. 2002 Dec;8(12):3702-9
references.pmid: 12473579
references.citation: J Infect Dis. 2007 May 1;195(9):1361-4
references.pmid: 17397008
references.citation: J Immunol. 2003 Oct 15;171(8):4352-8
references.pmid: 14530360
references.citation: J Exp Med. 2003 Apr 7;197(7):907-18
references.pmid: 12682110
references.citation: J Immunol. 2001 Oct 1;167(7):4046-50
references.pmid: 11564825
references.citation: Infect Immun. 2005 Jan;73(1):181-92
references.pmid: 15618153
references.citation: J Infect Dis. 1986 May;153(5):960-9
references.pmid: 3084667
references.citation: Nature. 2005 Mar 24;434(7032):525-9
references.pmid: 15791258
references.citation: J Immunol. 2003 Aug 15;171(4):1961-8
references.pmid: 12902499
references.citation: J Exp Med. 1995 Oct 1;182(4):993-1004
references.pmid: 7561702
references.citation: J Immunol. 2007 Oct 15;179(8):5126-36
references.pmid: 17911598
references.citation: Infect Immun. 2007 May;75(5):2171-80
references.pmid: 17353286
references.citation: Nature. 2005 Mar 24;434(7032):520-5
references.pmid: 15791257
references.citation: Nat Rev Immunol. 2004 Mar;4(3):231-7
references.pmid: 15039760
references.citation: J Immunol. 2001 Mar 1;166(5):3402-9
references.pmid: 11207297
references.citation: J Immunol. 2003 Oct 15;171(8):4020-7
references.pmid: 14530322
references.citation: J Virol. 2001 Jul;75(13):5965-76
references.pmid: 11390598
references.citation: Annu Rev Immunol. 1997;15:535-62
references.pmid: 9143699
references.citation: Nat Med. 2003 May;9(5):582-8
references.pmid: 12669034
references.citation: Nat Rev Microbiol. 2007 Jun;5(6):405-17
references.pmid: 17487145
references.citation: J Exp Med. 2002 Jul 1;196(1):119-27
references.pmid: 12093876
references.citation: J Exp Med. 1999 Apr 19;189(8):1315-28
references.pmid: 10209048
references.citation: J Clin Invest. 2005 Sep;115(9):2572-83
references.pmid: 16138194